Acadia Pharmaceuticals Inc

Allspring Global Investments Holdings, LLC ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/15/2026

Shares

658,813

Value ($000)

17,320

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/15/2026	17,320	0.0%	658,813	12/31/2025
2025 Q3	10/20/2025	11,160	0.0%	525,420	9/30/2025
2025 Q2	7/25/2025	9,205	0.0%	430,963	6/30/2025
2025 Q1	4/24/2025	5,065	0.0%	310,332	3/31/2025
2024 Q4	1/29/2025	764	0.0%	41,618	12/31/2024
2024 Q3	10/18/2024	1,871	0.0%	121,625	9/30/2024
2024 Q2	7/26/2024	1,769	0.0%	108,838	6/30/2024
2024 Q1	4/29/2024	1,088	0.0%	58,846	3/31/2024
2023 Q4	1/25/2024	4,606	0.0%	147,099	12/31/2023
2023 Q3	10/27/2023	2,607	0.0%	125,091	9/30/2023
2023 Q2	7/18/2023	910	0.0%	37,980	6/30/2023
2023 Q1	4/13/2023	1,675	0.0%	89,009	3/31/2023
2022 Q4	1/23/2023	149	0.0%	9,339	12/31/2022
2022 Q3	10/26/2022	193	0.0%	11,852	9/30/2022
2022 Q2	7/25/2022	166	0.0%	11,794	6/30/2022
2022 Q1	5/2/2022	1,507	0.0%	62,260	3/31/2022
2021 Q4	1/28/2022	1,374	0.0%	58,911	12/31/2021